-
-
-
-
-
-
-
This U.S. biotech stock is Bernstein's Top Pick for 2026
-
-
-
-
-
-
-
Amgen (AMGN) PT Lowered to $335 at Bernstein Amid MariTide Risk
-
-
-
-
-
-
-
William Blair Reiterates Outperform Rating on Amgen (AMGN)
-
-
-
-
-
-
-
Amgen stock falls as profit outlook disappoints investors
-
-
-
-
-
-
-
Amgen (AMGN) Tops Q3 EPS by 47c; offers guidance
-
-
-
-
-
-
-
Amgen (AMGN) Misses Q2 EPS by 1c; updates guidance
-
-
-
-
-
-
-
Ligand Reports First Quarter 2024 Financial Results
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

